Citigroup’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.1K | Buy |
46,330
+1,278
| +3% | +$2.74K | ﹤0.01% | 3681 |
|
|
2025
Q1 | $51.8K | Sell |
45,052
-11,952
| -21% | -$13.7K | ﹤0.01% | 4089 |
|
|
2024
Q4 | $125K | Buy |
57,004
+11,056
| +24% | +$24.2K | ﹤0.01% | 3879 |
|
|
2024
Q3 | $100K | Buy |
45,948
+28,093
| +157% | +$61.2K | ﹤0.01% | 3991 |
|
|
2024
Q2 | $41.2K | Buy |
17,855
+5,992
| +51% | +$13.8K | ﹤0.01% | 3964 |
|
|
2024
Q1 | $65.2K | Buy |
11,863
+2,049
| +21% | +$11.3K | ﹤0.01% | 3756 |
|
|
2023
Q4 | $24.2K | Sell |
9,814
-329
| -3% | -$813 | ﹤0.01% | 4158 |
|
|
2023
Q3 | $352K | Sell |
10,143
-35,507
| -78% | -$1.23M | ﹤0.01% | 2654 |
|
|
2023
Q2 | $1.5M | Buy |
45,650
+36,388
| +393% | +$1.19M | ﹤0.01% | 1930 |
|
|
2023
Q1 | $310K | Buy |
9,262
+4,345
| +88% | +$146K | ﹤0.01% | 2868 |
|
|
2022
Q4 | $161K | Buy |
4,917
+2,509
| +104% | +$82.3K | ﹤0.01% | 3146 |
|
|
2022
Q3 | $84K | Sell |
2,408
-122,104
| -98% | -$4.26M | ﹤0.01% | 3467 |
|
|
2022
Q2 | $1.52M | Buy |
124,512
+124,105
| +30,493% | +$1.52M | ﹤0.01% | 1770 |
|
|
2022
Q1 | $6K | Sell |
407
-2,419
| -86% | -$35.7K | ﹤0.01% | 4959 |
|
|
2021
Q4 | $56K | Buy |
+2,826
| New | +$56K | ﹤0.01% | 4241 |
|